Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENLIGHTEN: Detection by POSLUMA Following Negative Other PET-PSMA Imaging

NCT06813898 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06813898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06813898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENLIGHTEN: Detection by POSLUMA Following Negative Other PET-PSMA Imaging
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Recruiting
Start date
April 11, 2025
Completion date
February 1, 2032
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biochemically recurrent prostate carcinoma, prostate adenocarcinoma